Announcements

Conference: The 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD 2026)
Organization: European Association for the Study of Diabetes
Date: 28 September–2 October 2026
Place: Allianz MiCo—Milan Convention Centre, Milan, Italy
Booth Number: L.03

The 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from 28 September to 2 October 2026 at the Allianz MiCo - Milan Convention Centre in Milan, Italy. This global diabetes conference will convene thousands of delegates from all across the globe to explore the latest advancements in diabetes research, treatment, and care.​

The scientific programme will feature hundreds of presentations, including keynote lectures, symposia, and oral sessions, offering insights into cutting-edge developments in both basic and clinical diabetes research. Attendees will have the opportunity to engage with leading experts, fostering collaboration and knowledge exchange across the international diabetes community.​

The Organization of this conference, the European Association for the Study of Diabetes e.V. (EASD), is a membership-based academic non-profit organization. It was founded in 1965 and is based in Düsseldorf, Germany. The aims of EASD are to encourage and support research in the field of diabetes, the rapid diffusion of acquired knowledge and to facilitate its application.

The following open access journals will be represented:

• Biomedicines;
• Diabetology;
• JCM;
• Medicina;
• Endocrines;
• IJERPH;
• Antioxidants;
• Biomolecules;
• Epidemiologia;
• JMAHP;
• Nutrients;
• Trends in Public Health.

If you are attending the 62nd EASD Annual Meeting, we invite you to visit us at our booth #L.03. Our representatives will be available to discuss publishing opportunities, the benefits of open access, and answer any questions that you may have.

Join us in Milan to discover what is next in diabetes science and care! For more information about the conference, please visit its official website at https://www.easd.org/annual-meeting/easd-2026/.

We are honored to announce that Prof. Dr. William Gerwick will serve as the Chair of the 2026 Tu Youyou Award Committee.

A world-renowned authority in marine natural products chemistry and pharmacology, Professor Gerwick is a Distinguished Professor at both the Scripps Institution of Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego (UCSD). His pioneering work at the intersection of ocean sciences and drug discovery makes him a fitting leader for an award centered on transformative medicinal breakthroughs.

Under Professor Gerwick’s stewardship, the 2026 Tu Youyou Award Committee will focus on recognizing innovative and impactful research in natural products chemistry and medicinal chemistry, particularly work with the potential to drive meaningful advances in both scientific understanding and human health.

To provide further insight into his perspectives, we include below an interview with Professor Gerwick, in which he reflects on his scientific journey, his views on the field, and his vision for the Tu Youyou Award.

A Conversation with the Chair

1. Could you please introduce yourself and your research journey?

My research focuses on the natural products of marine algae and cyanobacteria, their application in medicine, their biosynthesis using genomic approaches, and innovative methods in the structure elucidation of natural products.

I received my BS degree from the University of California at Davis, my PhD from the University of California at San Diego, and conducted postdoctoral work at the University of Connecticut. After a couple of years in a junior faculty position at the Department of Chemistry at the University of Puerto Rico, I spent 21 years as Professor of Pharmacy at Oregon State University. In 2005, I returned to my PhD institution at the Scripps Institution of Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego, where I am currently a Distinguished Professor of Oceanography and Pharmaceutical Sciences.

Throughout my career, I have been dedicated to advancing the field through both leadership and mentorship. I have served as president of the American Society of Pharmacognosy, chaired and co-chaired several major research conferences, and served as an associate editor for the Journal of Natural Products. I am a Fellow of the American Association for the Advancement of Science (AAAS) and of the American Society of Pharmacognosy. I have trained over 100 doctoral and postdoctoral students, and my research group has published nearly 500 papers and more than 25 patents on topics in the natural product sciences and medicinal chemistry.

2. What motivated you to accept the role of Chair of the 2026 Tu Youyou Award Committee?

Of course, I am a huge supporter of all awards that are given in recognition of excellent scientific research, and especially so in the natural products sciences and medicinal chemistry. However, this award is truly special in that it recognizes scientific excellence as well as impact, and is given in the name of an individual, Tu Youyou, who clearly had many challenges along the path to reach the pinnacle of her success. Not only was she the first Chinese person to win a Nobel prize in this area, but she was also the first Chinese woman to receive a Nobel prize, and this was achieved without graduate education in China or elsewhere. It’s a true testament to what can be achieved by hard work, determination, and vision. To read the history of her extraordinary approach to discovering novel antimalarial compounds from Traditional Chinese Medicine is truly inspirational. It is, therefore, the inspiration provided by the extraordinary life and career of Tu Youyou that motivated me to accept the Chair of the Award Committee for 2026.

3. How do you view the role of natural products chemistry and medicinal chemistry in today’s scientific landscape, and what major advances over the past decade have shaped this field?

A quite remarkable integration of fields is currently transforming natural products science and medicinal chemistry. In natural products, we are seeing integration of different omics methods, from metabolites to proteins to nucleic acids. Sophisticated biological and pharmacological approaches are driving the discovery of exquisitely potent and selective natural products. Advances are being made to integrate molecular-level recognition of natural products with chemical ecological studies, and sophisticated methods of structure determination using Artificial Intelligence or pioneering new tools such as microED are being applied with increasing frequency. High-level synthetic methodologies, such as protecting group-free synthetic routes, are enhancing medicinal chemistry, accelerating the identification of lead molecules with attractive pharmaceutical properties at an increasing pace.

4. How do you consider the balance between fundamental discovery (e.g., new molecules or mechanisms) and practical impact (e.g., therapeutic applications)?

Many individuals are excellent scientists and mentors, and have essential roles in developing our culture that values science and the scientific method. It should also be pointed out that not all scientific discoveries are going to have a broad societal impact, but they are nevertheless critical to the overall body and structure of science. But it is a truly remarkable individual who makes a key scientific discovery, recognizes its potential value to society in general, and then has the skills and determination to bring it forward as a useful product. That was the type of person the Tu Youyou is, and that is the type of person who is honored by the prize in her name.

5. What do you see as the key challenges or opportunities currently facing the field?

We are on the crux of an amazing revolution in many of the sciences, including natural products and medicinal chemistry; the purposeful application of Artificial Intelligence to solving many of the difficulties involved in the search for new pharmaceuticals from Nature. AI is transforming how we select organisms for study, what pharmaceutical targets to go after, rapidly resolving the chemical structures of new compounds, identifying efficient routes to their chemical synthesis, understanding their molecular mechanisms of action, and finally, designing their clinical application. The role of people in these pursuits is changing. Increasingly, the human role will be providing overall vision: what can we do? What should we do? And it is important to remember that AI is providing hypotheses, not truth. Scientists with expert domain knowledge will be critical for discerning the correctness of hypotheses put forth by AI. Altogether, advances in technology, expanding knowledge, and the appropriate use of AI methods are preparing society to be able to address emerging diseases, such as pandemics, as well as conditions that are not effectively treated by currently existing therapeutics.

6. How do you expect the Tu Youyou Award to contribute to the advancement of natural product chemistry, medicinal chemistry, and human health over the coming years?

The Tu Youyou Award is potentially transformative for the broad fields of natural products science and medicinal chemistry as it brings a significantly increased level of visibility to these topics and their contributions to human health. It will be crucial to have excellent communication to news agencies, social media and other communication outlets so that the general public is informed and educated on the high impact of these natural product/medicinal chemistry contributions. This will bring increased funding, attract promising students, and generally enrich the interface of these fields with the health sector.

7. What message would you like to convey to the research community and the public during this open nomination phase?

This prize gives broad societal visibility to the role that natural products have had in shaping a majority of our current medicines, as well as understanding the life forms with whom we share the planet. Further, it recognizes a woman scientist working under sub-optimal conditions who could persevere and make discoveries of global impact. The prize and what it represents, therefore, inspires current and future generations to engage in the study of Nature and its relationship to Human Health, to overcome adversity, and to aspire to making one’s life impactful.

About the Tu Youyou Award

Established in 2016, the Tu Youyou Award seeks to honor those who excel in the fields of natural products chemistry and medicinal chemistry. This award offers a total prize of CHF 100,000, which will be equally divided among the winners if there is more than one, with each recipient receiving an award medal and a certificate.

The 2026 Tu Youyou Award is open for nominations until 31 October 2026. We encourage all eligible candidates to participate in this prestigious recognition, as this award not only honors individual achievement but also encourages further scientific exchange, exploration and discovery in critical areas of medicine.

If you are interested in participating, please visit the Tu Youyou Award website for more information on the nomination requirements.

MDPI will be attending NWO Life 2026, which will be held from 28 to 29 May 2026 in Egmond aan Zee, the Netherlands.

NWO Life is an annual scientific conference for life scientists, designed to inspire and connect researchers across disciplines. Attendees can engage with sessions led by world-leading keynote speakers and researchers, while also sharing their own work with a diverse community spanning all career stages.

The conference offers a dynamic platform to explore scientific knowledge beyond one’s immediate field. Over the course of two days, the programme is structured around a range of topics tailored to different research backgrounds, encouraging interdisciplinary learning and the exchange of fresh perspectives.

NWO Life supports researchers at every stage of their careers. Early career scientists gain valuable experience by presenting their research, while established researchers can discover new directions and build collaborations through plenary talks and poster sessions. With ample networking opportunities throughout, the conference fosters meaningful connections within the life sciences community.

The following MDPI journals will be represented at the conference:

• Life;
• Applied Biosciences;
• Organoids;
• MPs;
• JDB;
• Metabolites;
• Cells;
• IJERPH;
• Stresses;
• BioMedInformatics.

If you are planning to attend this conference, please feel free to stop by our booth and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following link: https://nwolife.nl/.

World Malaria Day, observed annually on 25 April, celebrates the importance of raising awareness of malaria and the preventive efforts to control the disease, with the ultimate goal of eradicating malaria worldwide.  With the development of new vaccines, treatments, malaria control tools, and pioneering technologies, ending malaria within our lifetime has become a real possibility.

In recognition of World Malaria Day, MDPI reaffirms its commitment to advancing cutting-edge and interdisciplinary research. Through open access publishing, we support the dissemination of discoveries in Public Health & Healthcare, Medicine & Pharmacology, Biology, Life Sciences, and related fields —ensuring knowledge is accessible and empowering researchers to contribute to the next generation of scientific and technological breakthroughs.

MDPI established the Tu Youyou Award in 2016 to honor Professor Tu Youyou’s remarkable contributions to human health and acknowledge exceptional scholars committed to the research fields of natural product and medicinal chemistry.

Prize:

• CHF 100,000 (to be divided equally should multiple recipients be awarded);
• An award medal and a certificate.

Nomination Deadline: 31 October 2026.

For further information, please visit the Tu Youyou Award website (https://tuyouyouprize.org/).
For any inquiries, please contact the Tu Youyou Award Team at tuyouyouaward@mdpi.com.

Prof. Eleni Patsoula, School of Public Health, University of West Attica, Athens, Greece	Prof. Oleksii Skorokhod, Department of Life Sciences and Systems Biology, University of Turin, Italy	Prof. Dr. Toshio Hattori, Roken Akanpe Nursing Home, Kurashiki, Okayama, Japan
Dr. Kostas Eleftheratos, School of Health Systems and Public Health, University of Pretoria, Institute for Sustainable Malaria Control (UP ISMC), South Africa	Dr. Michael Eisenhut, Cochrane Collaboration, UK

Register for this webinar for free here!

“Diagnostic Accuracy of Utilizing Artificial Intelligence for Malaria Diagnostic: A Systematic Review and Meta-Analysis”
by Icha Farihah Deniyati Faratisha, Khadijah Cahya Yunita,  Hanifa Rizky Rahmawati, Loeki Enggar Fitri, Nuning Winaris and Lailil Muflikah
Infect. Dis. Rep. 2026, 18(1), 11; https://doi.org/10.3390/idr18010011

“Enduring Warning: A Holistic Comparison of the Establishment and Spread of P. falciparum Evolutionary Lineage Malaria in Ancient Rome and the Threat of Zoonotic P. knowlesi Malaria in Modern Southeast Asia”
by Mark Orsag, Giovanni Meledandri, Amanda McKinney and Melissa Clouse
Zoonotic Dis. 2025, 5(4), 34; https://doi.org/10.3390/zoonoticdis5040034

“Evolutionary Trajectory of Plasmodium falciparum: From Autonomous Phototroph to Dedicated Parasite”
by Damian Pikor, Mikołaj Hurla, Alicja Drelichowska and Małgorzata Paul
Biomedicines 2025, 13(9), 2287; https://doi.org/10.3390/biomedicines13092287

“Correlation of Inflammatory Biomarkers and IgG4 Antibodies with Malaria in Cameroon’s Buea Municipality Children”
by Jerome Nyhalah Dinga, Flora Ayah, Emmanuel Fondungallah Anu, Haowen Qin, Stanley Dobgima Gamua, Anthony Kukwah Tufon, Magloire Essissima Amougou and  Rameshbabu Manyam
Diseases 2025, 13(4), 123; https://doi.org/10.3390/diseases13040123

“Alterations in von Willebrand Factor Levels in Patients with Malaria: A Systematic Review and Meta-Analysis of Disease Severity”
by Suriyan Sukati, Rujikorn Rattanatham, Frederick Ramirez Masangkay, Ching-Ping Tseng and Manas Kotepui
Medicina 2025, 61(4), 767; https://doi.org/10.3390/medicina61040767

“Genetic Diversity of Potential Drug Resistance Markers in Plasmodium vivax Isolates from Panama, Mesoamerica”
by Vanessa Vásquez, Ana María Santamaría, Dianik Moreno, Fergie Ruíz, Chystrie A. Rigg, Luis F. Chaves and José E. Calzada
Pathogens 2025, 14(3), 231; https://doi.org/10.3390/pathogens14030231

“Duplication of a Type-P5B-ATPase in Laverania and Avian Malaria Parasites and Implications About the Evolution of Plasmodium”
by Mark F. Wiser
Parasitologia 2025, 5(1), 6; https://doi.org/10.3390/parasitologia5010006

“Identification of Malaria-Selective Proteasome β5 Inhibitors Through Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation”
by Muhammad Yasir, Jinyoung Park, Eun-Taek Han, Jin-Hee Han, Won Sun Park and Wanjoo Chun
Int. J. Mol. Sci. 2024, 25(22), 11881; https://doi.org/10.3390/ijms252211881

“Antimalarial Mechanisms and Resistance Status of Artemisinin and Its Derivatives”   
by Dan Zheng,  Tingting Liu, Shasha Yu, Zhilong Liu, Jing Wang and Ying Wang
Trop. Med. Infect. Dis. 2024, 9(9), 223; https://doi.org/10.3390/tropicalmed9090223

“Sensitivity Assessment of a Multiplex and Real-Time PCR Protocols for the Detection of Malaria in External Quality Control Samples in the Malaria Reference Center in Greece”
by Nikolaos Tegos, Christos Goumenopoulos, Anastasia Mpimpa, Vasilios Papavasilopoulos, Stavroula Beleri and Eleni Patsoula
Parasitologia 2024, 4(2), 150-161; https://doi.org/10.3390/parasitologia4020013

“Targeting Plasmodium Life Cycle with Novel Parasite Ligands as Vaccine Antigens”
by Shan Khan, Manas Paresh Patel, Aleem Damji Patni and Sung-Jae Cha
Vaccines 2024, 12(5), 484; https://doi.org/10.3390/vaccines12050484

“Advances in Microparasite Research”  Guest Editors: Dr. Sofia Nolasco and Dr. Inês L. S. Delgado   Submission deadline: 31 July 2026	“Malaria in a Changing World” Guest Editors: Dr. Harry Tagbor and Dr. Luiz Shozo Ozaki Submission deadline: 20 August 2026
“Genetic and Molecular Research on the Malaria Parasite” Guest Editors: Prof. Dr. Hajime Hisaeda and Dr. Takashi Imai Submission deadline: 20 September 2026	“Advances in Tools for Battling Malaria” Guest Editors: Dr. Wenn-Chyau Lee and Dr. Meng Yee Lai Submission deadline: 31 December 2026

In order to further enhance the international influence of the International Journal of Environmental Research and Public Health (IJERPH, ISSN: 1660-4601), promote the academic exchange of young scientists, and support the Editorial Board with additional expertise, IJERPH is inviting interested and eligible early career researchers to apply for Early Career Editorial Board (ECEB) membership.

A total of 30 Early Career Editorial Board Members are planned to be recruited. Early Career Editorial Board (ECEB) members will hold the position for two years with the possibility of renewal for a second term.

Application eligibility:

• Completed their doctorate/PhD degree in the past 10 years (considering exceptions for career interruptions, including medical and family leave);
• Evidence of significant research achievements in the field of public health;
• Willingness to dedicate their time to the development of the journal with passion and enthusiasm;
• Researchers that are active and engaged in their community (e.g., experienced at presenting at academic conferences or involved in professional organizations).

Benefits of an Early Career Editorial Board Member:

• A certificate of appointment as an Early Career Editorial Board Member will be provided;
• The achievements of Early Career Editorial Board Members are publicized on journal media platforms to improve academic visibility;
• An opportunity to be promoted to Editorial Board Member based on contributions;
• The journal will regularly acknowledge those who participated in the peer-review process on the journal website;
• Opportunities to participate in or host annual meetings and online seminars organized by the Editor-in-Chief and the Editorial Board Members.

Responsibilities of an Early Career Editorial Board Member:

• Publicizing and promoting the journal at academic conferences and among peers;
• Selecting high-quality articles and preparing bilingual media content for promotion;
• Reviewing at least four manuscripts per year;
• Providing input on any new initiatives of journal development;
• Inviting submissions from local and overseas world-leading scientists in respective research fields.

Applications:
Please fill in the application form here.

Please send the application form and your academic resume to ijerph@mdpi.com with the subject of “IJERPH Early Career Editorial Board Application + Name + Institute + Research Expertise”.

Application deadline: 31 July 2026.

Selection process and announcement:
The selection process: initial screening of application materials → selection by the Editor-in-Chief and Editorial Board Members → email notification → issuing of a certificate of appointment.

The selection will be made within one month of the application deadline and the results will be announced on the journal website.

MDPI is excited to announce a special webinar in celebration of World Malaria Day on 24 April 2026. This event will promote public understanding of malaria diagnosis and prevention, as well as highlight the development of pioneering technologies that have made malaria elimination possible.

Date: 24 April at 10:00 a.m. CEST | 4:00 p.m. CST Asia
Webinar ID: 847 7074 5022
Webpage: https://sciforum.net/event/MWMDW

Register now for free:

Program:

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic and institutional email addresses will be prioritized.

Unable to attend? Register anyway, and we will let you know when the recording is available to watch.

Keynote Speakers:

• Prof. Eleni Patsoula, School of Public Health, University of West Attica, Athens, Greece;
• Prof. Oleksii Skorokhod, Department of Life Sciences and Systems Biology, University of Turin, Via Accademia Albertina 13, 10123 Turin, Italy;
• Prof. Dr. Toshio Hattori, Roken Akanpe Nursing Home, Kurashiki, Okayama, Japan;
• Dr. Ashley Burke, School of Health Systems and Public Health, University of Pretoria Institute for Sustainable Malaria Control (UP ISMC), South Africa;
• Dr. Michael Eisenhut, Cochrane Collaboration, UK.

Relevant Special Issues:
“Advances in Microparasite Research”
Guest Editors: Dr. Sofia Nolasco and Dr. Inês L. S. Delgado
Submission deadline: 31 July 2026

“Malaria in a Changing World”
Guest Editors: Dr. Harry Tagbor and Dr. Luiz Shozo Ozaki
Submission deadline: 20 August 2026

“Genetic and Molecular Research on the Malaria Parasite "
Guest Editors: Prof. Dr. Hajime Hisaeda and Dr. Takashi Imai
Submission deadline: 20 September 2026

“Advances in Tools for Battling Malaria”
Guest Editors: Dr. Wenn-Chyau Lee and Dr. Meng Yee Lai
Submission deadline: 31 December 2026

“Recent Advances in Malaria Vaccine Development—2nd Edition”
Guest Editors: Dr. Ahmad Rushdi Shakri and Dr. Dipak Raj
Submission deadline: 31 December 2026

Our portfolio of journals available for publishing up-to-date research in immediate open access format has been further expanded. In the first quarter of 2026, nine new journals released their inaugural issues and three transferred journals released their first issue as part of MDPI, covering the subjects of clinical medicine, chemistry, computer science & mathematics, engineering, environment & ecology, and social sciences & psychology.

We extend our gratitude to the Editors-in-Chief, Associate Editors, and Editorial Board Members who will shape the future course of these brand-new journals. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.

Please feel free to browse and discover more about the new journals below.

We would like to thank everyone who has supported the development of open access publishing. If you would like to create a new journal, you are welcome to send an application here or contact the New Journal Committee (newjournal-committee@mdpi.com).

To further enhance the quality of the International Journal of Environmental Research and Public Health (IJERPH, ISSN: 1660-4601) and its published papers, under the guidance of our Section Editor-in-Chief, Prof. Dr. Germán Vicente-Rodríguez, the journal has updated and revised the scope of the Section “Exercise and Health-Related Quality of Life”. The original scope and the updated scope are listed below. 

For more detailed information, please visit the following link: https://www.mdpi.com/journal/ijerph/sections/exercise_and_health-related_quality_of_life.

IJERPH Editorial Office

MDPI is excited to announce its participation as an exhibitor at the 2026 American College of Sports Medicine Annual Meeting, taking place in Salt Lake City, UT, USA, from 26 to 29 May 2026.

In 2026, ACSM’s Annual Meeting Spotlight will focus on the powerful convergence of Physical Activity, Exercise, and Technology. Technology transforms how physical activity is studied, prescribed, and experienced—from wearable devices and AI-driven interventions to virtual platforms and advanced diagnostics. This year’s spotlight will explore the intersection of basic, applied, and/or clinical science as it relates to the collective impact of physical activity, exercise, and technological advancement. Sessions in this track should reflect how innovations in technology enhance scientific understanding, clinical outcomes, performance, or population health. Through this spotlight, ACSM aims to highlight research and initiatives that are not only shaping the future of the field but also advancing its mission to extend and enrich lives through the power of movement.

The following open access journals will be represented at the conference:

• Sports;
• JFMK;
• Physiologia;
• Obesities;
• JCM;
• JAPMA;
• Diabetology;
• IJERPH;
• Antioxidants;
• Biomechanics.

If you are planning to attend this conference, please get in touch with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following website: https://acsm.org/events-general/annual-meeting/exhibit-sponsor/.

World Health Day, observed annually on 7 April, highlights the global commitment to improving public health and ensuring that all people have access to quality healthcare. Established by the World Health Organization, the day draws attention to pressing health challenges and mobilizes collective action to strengthen health systems, advance medical research, and promote well-being worldwide.

Despite significant progress in medicine and public health, many individuals and communities continue to face barriers to healthcare, including unequal access to services, limited resources, and emerging global health threats. These interconnected challenges highlight the importance of sustained research, international collaboration, and evidence-based policies to improve health outcomes and build resilient healthcare systems.

In support of World Health Day 2026 and the United Nations Sustainable Development Goal 3: Good Health and Well‑Being, MDPI journals from the Public Health & Healthcare subject aim to foster interdisciplinary dialogue and research on global health, disease prevention, and healthcare innovation. Through Special Issues and research articles, MDPI provides platforms to explore health challenges from diverse perspectives, including public health, clinical medicine, epidemiology, and health policy.

We are delighted to announce that nominations are now open for the 2026 Tu Youyou Award. Named after Nobel Laureate Tu Youyou, whose discovery of artemisinin has saved millions of lives, this award recognizes researchers whose work advances the fields of natural products chemistry and medicinal chemistry, while also contributing to human health.

“Breastfeeding in Infancy and Adult Health: A Narrative Review”
by Eleftherios Panteris, Ioanna Kakatsaki, Ourania Galani, Zoi Koukou and Eleftheria Hatzidaki
Children 2026, 13(2), 286; https://doi.org/10.3390/children13020286

“Bridging the Gap: Health Education Needs Among Rural Populations with Chronic Illness and Low Health Literacy in Unincorporated Communities in Southern California”
by Shiloh A. Williams, Ryan C. Shriver and Candace C. Juhala
Int. J. Environ. Res. Public Health 2026, 23(1), 21; https://doi.org/10.3390/ijerph23010021

“Predicting Workplace Hazard, Stress and Burnout Among Public Health Inspectors: An AI-Driven Analysis in the Context of Climate Change”
by Ioannis Adamopoulos, Antonios Valamontes, Panagiotis Tsirkas and George Dounias
Eur. J. Investig. Health Psychol. Educ. 2025, 15(5), 65; https://doi.org/10.3390/ejihpe15050065

“Clinical and Public Health Challenge of Handling Synthetic Cathinone and Cannabinoid Abuse in Pediatric Care: A Narrative Review”
by Valerio Ricci and Giuseppe Maina
Pediatr. Rep. 2025, 17(1), 19; https://doi.org/10.3390/pediatric17010019

 “Factors Affecting Online Health Promotion Program Adherence Among People with Disabilities”
by Madison Mintz, Robert A. Oster, Jereme Wilroy and James H. Rimmer
Disabilities 2025, 5(1), 16; https://doi.org/10.3390/disabilities5010016

“Digital Twins’ Advancements and Applications in Healthcare, Towards Precision Medicine”
by Konstantinos Papachristou, Paraskevi F. Katsakiori, Panagiotis Papadimitroulas, Lidia Strigari and George C. Kagadis
J. Pers. Med. 2024, 14(11), 1101; https://doi.org/10.3390/jpm14111101

”European Nurses’ Burnout before and during the COVID-19 Pandemic and Its Impact on Patient Safety: A Scoping Review”
by Goitseone Mogomotsi and Jennifer Creese
Hospitals 2024, 1(2), 151-171; https://doi.org/10.3390/hospitals1020013

“Framework to Support the Transfer of Innovative Interventions in the Disability Field: Lessons from the Transferability of Complex Interventions in Public Health: A Review”
by Eléonore Ségard, Philippe Chervin and Linda Cambon
Disabilities 2024, 4(3), 724-740; https://doi.org/10.3390/disabilities4030044

“Body-Related Attitudes, Self-Esteem, and Psychological Wellbeing” Guest Editors: Dr. Anne-Mette Hermans, Dr. Rebecca Nash and Dr. Helena Lewis-Smith Submission deadline: 30 June 2026	“Reducing Health Disparities: The Role of Health Literacy and Health Promotion” Guest Editor: Prof. Dr. Hae-Ra Han Submission deadline: 31 July 2026
“Ehealth, Telemedicine, and AI in the Precision Medicine Era” Guest Editor: Dr. Mirella Veras Submission deadline: 20 August 2026	“Emergency and Disaster Medicine: Preparedness, Response, and Resilience in Health Systems” Guest Editor: Dr. Ulrich Sack Submission deadline: 31 October 2026

The 2nd International One Health Conference Location: Barcelona, Spain Volume Editors: Margherita Ferrante and Gea Oliveri Conti Highlights: “Climate Crises Associated with Epidemiological, Environmental, and Ecosystem Effects of a Storm: Flooding, Landslides, and Damage to Urban and Rural Areas (Extreme Weather Events of Storm Daniel in Thessaly, Greece)” by Ioannis Adamopoulos, Aikaterini Frantzana and Niki Syrou “Public Health Implications of Antimicrobial Resistance in Wildlife at the One Health Interface” by Julio A. Benavides, Marilia Salgado-Caxito, Carmen Torres and Sylvain Godreuil Click here to read the full list of papers.